4.8 Review

Chemical transformation of xenobiotics by the human gut microbiota

期刊

SCIENCE
卷 356, 期 6344, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aag2770

关键词

-

资金

  1. Smith Family Award for Biomedical Research
  2. Damon Runyon-Rachleff Innovation Award
  3. George W. Merck Fellowship
  4. David and Lucille Packard Foundation
  5. Howard Hughes Medical Institute-Gates Faculty Scholar Award [OPP1158186]
  6. Massachusetts Institute of Technology Center for Microbiome Informatics and Therapeutics
  7. Sloan Research Fellowship
  8. Blavatnik Biomedical Accelerator Award
  9. Takeda
  10. Defense Advanced Research Projects Agency [HR0011-16-2-0013]
  11. NIH [CA208834, 5T32GM007598]
  12. NSF [MCB-1650086, DGE1144152]
  13. Bill and Melinda Gates Foundation [OPP1158186] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

The human gut microbiota makes key contributions to the metabolism of ingested compounds (xenobiotics), transforming hundreds of dietary components, industrial chemicals, and pharmaceuticals into metabolites with altered activities, toxicities, and lifetimes within the body. The chemistry of gut microbial xenobiotic metabolism is often distinct from that of host enzymes. Despite their important consequences for human biology, the gut microbes, genes, and enzymes involved in xenobiotic metabolism are poorly understood. Linking these microbial transformations to enzymes and elucidating their biological effects is undoubtedly challenging. However, recent studies demonstrate that integrating traditional and emerging technologies can enable progress toward this goal. Ultimately, a molecular understanding of gut microbial xenobiotic metabolism will guide personalized medicine and nutrition, inform toxicology risk assessment, and improve drug discovery and development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据